Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-017899
Filing Date
2017-07-05
Accepted
2017-07-05 20:28:38
Documents
1
Period of Report
2017-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9428
  Complete submission text file 0000899243-17-017899.txt   10976
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address OMC CHAMBERS WICKHAMS CAY1, ROAD TOWN TORTOLA D8 VG1110
Business Address OMC CHAMBERS WICKHAMS CAY1, ROAD TOWN TORTOLA D8 VG1110 971 55 222 2789
KCK LTD. (Reporting) CIK: 0001657662 (see all company filings)

State of Incorp.: D8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38130 | Film No.: 17950605